A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients (Q45250754)
Jump to navigation
Jump to search
scientific article published on 30 May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients |
scientific article published on 30 May 2010 |
Statements
1 reference
A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients (English)
1 reference
M Siebels
1 reference
K Rohrmann
1 reference
R Oberneder
1 reference
M Stahler
1 reference
N Haseke
1 reference
J Beck
1 reference
R Hofmann
1 reference
M Kindler
1 reference
P Kloepfer
1 reference
C Stief
1 reference
30 May 2010
1 reference
1 reference
29
1 reference
1
1 reference
121-126
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference